These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 17215845

  • 1. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB.
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [Abstract] [Full Text] [Related]

  • 2. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
    Dresser GK, Kim RB, Bailey DG.
    Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
    [Abstract] [Full Text] [Related]

  • 3. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
    Bailey DG, Dresser GK, Leake BF, Kim RB.
    Clin Pharmacol Ther; 2007 Apr; 81(4):495-502. PubMed ID: 17301733
    [Abstract] [Full Text] [Related]

  • 4. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.
    Shirasaka Y, Kuraoka E, Spahn-Langguth H, Nakanishi T, Langguth P, Tamai I.
    J Pharmacol Exp Ther; 2010 Jan; 332(1):181-9. PubMed ID: 19779132
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
    Banfield C, Gupta S, Marino M, Lim J, Affrime M.
    Clin Pharmacokinet; 2002 Jan; 41(4):311-8. PubMed ID: 11978146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of grapefruit juice on digoxin pharmacokinetics in humans.
    Becquemont L, Verstuyft C, Kerb R, Brinkmann U, Lebot M, Jaillon P, Funck-Brentano C.
    Clin Pharmacol Ther; 2001 Oct; 70(4):311-6. PubMed ID: 11673746
    [Abstract] [Full Text] [Related]

  • 10. Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects.
    Rebello S, Zhao S, Hariry S, Dahlke M, Alexander N, Vapurcuyan A, Hanna I, Jarugula V.
    Eur J Clin Pharmacol; 2012 May; 68(5):697-708. PubMed ID: 22124880
    [Abstract] [Full Text] [Related]

  • 11. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
    Christensen H, Asberg A, Holmboe AB, Berg KJ.
    Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption.
    Shirasaka Y, Shichiri M, Murata Y, Mori T, Nakanishi T, Tamai I.
    Drug Metab Dispos; 2013 Mar; 41(3):615-21. PubMed ID: 23264447
    [Abstract] [Full Text] [Related]

  • 14. [Grapefruit juice and drugs: a hazardous combination?].
    Lohezic-Le Devehat F, Marigny K, Doucet M, Javaudin L.
    Therapie; 2002 Mar; 57(5):432-45. PubMed ID: 12611197
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of drug interactions involving fruit beverages and organic anion-transporting polypeptides.
    Greenblatt DJ.
    J Clin Pharmacol; 2009 Dec; 49(12):1403-7. PubMed ID: 19789373
    [Abstract] [Full Text] [Related]

  • 17. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
    Kamath AV, Yao M, Zhang Y, Chong S.
    J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603
    [Abstract] [Full Text] [Related]

  • 18. A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect".
    Won CS, Lan T, Vandermolen KM, Dawson PA, Oberlies NH, Widmer WW, Scarlett YV, Paine MF.
    J Clin Pharmacol; 2013 Sep; 53(9):982-90. PubMed ID: 23878024
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.